[1] |
唐晓娣.α-人重组干扰素联合唯阴康协助宫颈LEEP刀治疗宫颈柱状上皮外翻及不典型增生疗效比较[J].河北医药,2011,33(23):3600-3601.
|
[2] |
彭雪.宫颈LEEP术联合干扰素治疗难治性宫颈炎53例临床观察[J].医学信息,2014,14(24):450-451.
|
[3] |
柳林康,徐晶,杨春莲,等.保妇康凝胶联合干扰素对宫颈LEEP手术治疗后宫颈修复的疗效观察[J].实用中西医结合临床,2014,14(8):30-31.
|
[4] |
Praud A,Boschiroli ML,Meyer L,et al.Assessment of the sensitivity of the gamma-interferon test and the single intradermal comparative cervical test for the diagnosis of bovine tuberculosis under field conditions[J].Epidemiol Infect,2015,143(1):157-166.
|
[5] |
韩光琳.宫颈LEEP术联合干扰素在难治性宫颈炎治疗中的体会[J].中国卫生产业,2013,13(25):93-94.
|
[6] |
余野,葛红雨,刘会换,等.重组干扰素胶囊在宫颈上皮内瘤变宫颈电环切除术后的临床应用观察[J].内蒙古中医药,2014,33(12):65-66.
|
[7] |
Lace MJ,Anson JR,Haugen TH,et al.Interferon treatment of human keratinocytes harboring extrachromosomal,persistent HPV-16 plasmid genomes induces de novo viral integration[J].Carcinogenesis,2015,36(1):151-159.
|
[8] |
刘正英.难治性宫颈炎采用宫颈LEEP术联合干扰素治疗的效果探讨[J].世界最新医学信息文摘(连续型电子期刊),2016,21(7):63-64.
|
[9] |
韩淑琴,刘俊霞,耿英桥,等.重组人干扰素α-2b阴道泡腾胶囊联合LEEP术治疗宫颈高危HPV感染的临床观察[J].河北医药,2014,36(10):1511-1512.
|
[10] |
沈琼.LEEP联合干扰素对宫颈糜烂患者细胞免疫功能、病灶组织凋亡分子、高危型HPV-DNA表达的影响[J].海南医学院学报,2015,21(1):99-101.
|
[11] |
Scott ME,Ma Y,Farhat S,et al.Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response[J].Int JCancer,2015,136(10):2402-2408.
|
[12] |
钱培英,余深锁.重组人干扰素α-2b联合LEEP术治疗有症状的宫颈柱状上皮异位疗效观察[J].中国药师,2015,24(4):600-602.
|
[13] |
杨琳,张金玲,张立杰,等.4种疗法对宫颈上皮内瘤变Ⅰ级的治疗效果比较[J].山东医药,2013,53(11):59-60.
|
[14] |
唐文娟.α-2b干扰素在LEEP刀治疗宫颈上皮内瘤变围术期应用的疗效分析[J].河北医学,2014,20(1):119-121.
|
[15] |
谷丽静.LEEP刀宫颈锥切术联合术前术后应用重组α-2b干扰素栓治疗宫颈上皮内瘤变临床疗效分析[J].中国计划生育学杂志,2015,23(9):600-602.
|